Abbott Laboratories was pilloried last week by regulators for, in part, botching its response to a report that certain company defibrillators and pacemakers could be manipulated by hackers. Shares of the health-care giant, which acquired the devices in its purchase of St. Jude Medical Inc., fell 1.9%.

Comments

No comments to display.